Aethlon Medical

Q1 FY2027 EarningsFY27 Q1 results for AEMD showed a narrow beat on the bottom line, with a GAAP net loss of $1.55M vs. the $1.85M consensus loss. Revenue remained at zero as expected for this clinical-stage company. Operating expenses fell 11.9% YoY to $1.58M, better than the projected EBIT loss of $1.89M. EPS loss of $4.02 was slightly wider than the $3.93 consensus due to share count fluctuations, though post-quarter financing of $4.0M provides a needed liquidity runway.